SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-07-03 13:04
Tx date 2025-06-30
$HLS
HLS Therapeutics Inc.
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights
$40,129
+8,343 vol
$4.81 each
111,838
Filed 2025-04-01 12:06
Tx date 2025-03-31
$HLS
HLS Therapeutics Inc.
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights
$42,055
+9,243 vol
$4.55 each
103,495
Filed 2025-01-03 15:27
Tx date 2024-12-31
$HLS
HLS Therapeutics Inc.
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights
$43,716
+11,596 vol
$3.77 each
94,252
Filed 2024-10-03 09:54
Tx date 2024-09-30
$HLS
HLS Therapeutics Inc.
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights
$37,142
+10,204 vol
$3.64 each
82,656
Filed 2024-07-05 10:22
Tx date 2024-06-30
$HLS
HLS Therapeutics Inc.
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights
$37,639
+11,038 vol
$3.41 each
72,452
Filed 2024-04-01 14:11
Tx date 2024-03-31
$HLS
HLS Therapeutics Inc.
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights
$37,262
+9,806 vol
$3.80 each
61,414
Filed 2024-03-25 13:48
Tx date 2024-03-25
$HLS
HLS Therapeutics Inc.
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights
$203,114
+49,783 vol
$4.08 each
51,608
Filed 2022-12-16 16:07
Tx date 2022-12-12
$HLS
HLS Therapeutics Inc.
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights
$18,450
+1,825 vol
$10.11 each
1,825
Filed 2022-12-16 16:06
Tx date 2022-11-28
$HLS
HLS Therapeutics Inc.
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
DSU
00 - Opening Balance-Initial SEDI Report
Filed 2022-12-05 13:02
Tx date 2022-11-28
$HLS
HLS Therapeutics Inc.
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,765